Dipartimento di Scienze Farmaceutiche "P. Pratesi", Università degli Studi di Milano, via G. Colombo 71, 20133 Milano, Italy.
J Control Release. 2012 May 10;159(3):324-31. doi: 10.1016/j.jconrel.2012.01.001. Epub 2012 Jan 10.
Injection Molding (IM) consists in the injection, under high pressure conditions, of heat-induced softened materials into a mold cavity where they are shaped. The advantages the technique may offer in the development of drug products concern both production costs (no need for water or other solvents, continuous manufacturing, scalability, patentability) and technological/biopharmaceutical characteristics of the molded items (versatility of the design and composition, possibility of obtaining solid molecular dispersions/solutions of the active ingredient). In this article, process steps and formulation aspects relevant to IM are discussed, with emphasis on the issues and advantages connected with the transfer of this technique from the plastics industry to the production of conventional and controlled-release dosage forms. Moreover, its pharmaceutical applications thus far proposed in the primary literature, intended as either alternative manufacturing strategies for existing products or innovative systems with improved design and performance characteristics, are critically reviewed.
注塑成型(IM)是指在高温高压条件下,将受热软化的材料注入模具型腔中进行成型。该技术在药物产品开发方面具有优势,包括生产成本(无需水或其他溶剂、连续制造、可扩展性、可专利性)和成型制品的技术/生物制药特性(设计和组成的多样性、获得活性成分的固体分子分散体/溶液的可能性)。本文讨论了与注塑成型相关的工艺步骤和配方方面,重点介绍了将该技术从塑料行业转移到常规和控释剂型生产中所涉及的问题和优势。此外,还对该技术在主要文献中迄今为止提出的制药应用进行了批判性审查,这些应用旨在作为现有产品的替代制造策略,或者是具有改进设计和性能特性的创新系统。